Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Head and Neck Neoplasms × camrelizumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 9 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Uterine Cervical Neoplasms 2 Nasopharyngeal Carcinoma 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Cervical Cancer Metastatic 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma 2 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Non-squamous Non-small-cell Lung Cancer 1 Mouth Neoplasms 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Leukemia, Myeloid, Acute 1 Laryngeal Neoplasms 1 Gestational Trophoblastic Disease 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Squamour Cell Cancer 1 Endometrioid Endometrial Cancer 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Gastric Cancer 1

Interventions

pembrolizumab 49 Cisplatin 38 Radiotherapy 24 Cetuximab 22 Carboplatin 20 Nivolumab 15 Paclitaxel 14 Docetaxel 14 Surveys and Questionnaires 11 Fluorouracil 11 Drug Therapy 10 Blood Specimen Collection 10 Radiotherapy, Intensity-Modulated 8 tislelizumab 7 atezolizumab 6 Radiation 6 Standard of Care 5 Afatinib 5 cemiplimab 4 Chemoradiotherapy 4 toripalimab 3 palbociclib 3 dostarlimab 3 Surgical Procedures, Operative 3 Magnetic Resonance Spectroscopy 3 Immune Checkpoint Inhibitors 3 Fulvestrant 3 Erlotinib Hydrochloride 3 Equipment and Supplies 3 Capecitabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡